PharmEng Announces Exclusive Agreement With Chinese Manufacturer for Distribution of Acetaminophen to North America Resulting in Significant Raw Material Cost Savings

TORONTO, ONTARIO -- (MARKET WIRE) -- March 26, 2007 -- PharmEng International Inc. (“PharmEng” or the “Company”) (TSX VENTURE: PII), today announced an exclusive distribution agreement with Bengbu Bayi Pharmaceuticals Ltd. of China for the distribution of acetaminophen for North America, Central America and South America. The contract period is for eight (8) years. Annual North American consumption of acetaminophen, used for pain and fever reduction in private label products, is approximately 50,000 metric tons per year or US$200 M / year.

MORE ON THIS TOPIC